The Tisch Cancer Institute Mount Sinai Health System Icahn School of Medicine at Mount Sinai — New York, New York

The Tisch Cancer Institute Mount Sinai Health System Icahn School of Medicine at Mount Sinai is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

The Tisch Cancer Institute Mount Sinai Health System Icahn School of Medicine at Mount Sinai has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumor.

Sponsors: Shanghai YingLi Pharmaceutical Co. Ltd..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Tisch Cancer Institute Mount Sinai Health System Icahn School of Medicine at Mount Sinai?

The Tisch Cancer Institute Mount Sinai Health System Icahn School of Medicine at Mount Sinai has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Tisch Cancer Institute Mount Sinai Health System Icahn School of Medicine at Mount Sinai conducted?

The Tisch Cancer Institute Mount Sinai Health System Icahn School of Medicine at Mount Sinai has 1 clinical trials on record. Their work covers Advanced Solid Tumor.

Is The Tisch Cancer Institute Mount Sinai Health System Icahn School of Medicine at Mount Sinai accredited by Crixeo Health?

The Tisch Cancer Institute Mount Sinai Health System Icahn School of Medicine at Mount Sinai has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Tisch Cancer Institute Mount Sinai Health System Icahn School of Medicine at Mount Sinai?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.